Merck, MBD0016-1ML, Inactivated Pseudomonas aeruginosa

General description
Standardization of sample analysis is currently needed in microbiome genomics research workflow. Lack of standardization can lead to biases and errors in common processes during sample preparation and analysis such as sample amplification, sequencing and bioinformatics analyses. Inactivated Pseudomonas Aeruginosa can serve as standard for benchmarking the performance along the workflow of microbiomics or meta-genomics analyses and as a tool to increase reproducibility and allow comparison of results obtained by different labs.

Pseudomonas aeruginosa is a gram negative aerobic to facultative anaerobe rod shaped bacteria which commonly inhabits soil and aqueous environments. In cases of a compromised immune system Pseudomonas aeruginosa can be an opportunistic pathogen. Its devastating effect is mostly known in Cystic Fibrosis (CF) patients. In addition, it often poses a major problem in burn wounds, chronic wounds, and in chronic obstructive pulmonary Disorder (COPD). P.aeruginosa forms biofilms on implanted biomaterials within hospital surface and water supplies. The international nosocomial infection control consortium reported that P. aeruginosa nosocomial infections have become a worldwide healthcare issue.

Read here how to use our standards to ensure data integrity for your microbiome research.
Application
Inactivated bacteria are provided at >10^8 bacteria/mL concentration in DPBS buffer pH 7.2. It is recommended to avoid freeze thaw cycles of this product.
Suitable for Quantitative standard for PCR, Sequencing and NGS
Features and Benefits
Individual microbial standard for microbiomics and meta-genomics workflow
Suitable standard for PCR, sequencing and NGS
Improve Bioinformatics analyses
Increases reproducibility
Compare results lab to lab

Physical form
Liquid -The inactivated bacteria is provided at >10^8 bacteria/mL in DPBS buffer pH 7.2